Stephen Mayo - Net Worth and Insider Trading

Stephen Mayo Net Worth

The estimated net worth of Stephen Mayo is at least $925,784 dollars as of 2024-04-28. Stephen Mayo is the Director of Sarepta Therapeutics Inc and owns about 6,621 shares of Sarepta Therapeutics Inc (SRPT) stock worth over $852,586. Stephen Mayo is also the Director of Allogene Therapeutics Inc and owns about 25,328 shares of Allogene Therapeutics Inc (ALLO) stock worth over $73,198. Details can be seen in Stephen Mayo's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Stephen Mayo has not made any transactions after 2024-03-05 and currently still holds the listed stock(s).

Transaction Summary of Stephen Mayo

To

Stephen Mayo Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Stephen Mayo owns 4 companies in total, including Merck & Co Inc (MRK) , Sarepta Therapeutics Inc (SRPT) , and Merck & Co Inc (MRKPRB.PFD) among others .

Click here to see the complete history of Stephen Mayo’s form 4 insider trades.

Insider Ownership Summary of Stephen Mayo

Ticker Comapny Transaction Date Type of Owner
MRK Merck & Co Inc 2021-03-15 director
SRPT Sarepta Therapeutics Inc 2024-03-05 director
MRKPRB.PFD Merck & Co Inc 2021-03-15 director
ALLO Allogene Therapeutics Inc 2023-08-07 director

Stephen Mayo Latest Holdings Summary

Stephen Mayo currently owns a total of 2 stocks. Among these stocks, Stephen Mayo owns 6,621 shares of Sarepta Therapeutics Inc (SRPT) as of March 5, 2024, with a value of $852,586 and a weighting of 92.09%. Stephen Mayo also owns 25,328 shares of Allogene Therapeutics Inc (ALLO) as of August 7, 2023, with a value of $73,198 and a weighting of 7.91%.

Latest Holdings of Stephen Mayo

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SRPT Sarepta Therapeutics Inc 2024-03-05 6,621 128.77 852,586
ALLO Allogene Therapeutics Inc 2023-08-07 25,328 2.89 73,198

Holding Weightings of Stephen Mayo


Stephen Mayo Form 4 Trading Tracker

According to the SEC Form 4 filings, Stephen Mayo has made a total of 2 transactions in Sarepta Therapeutics Inc (SRPT) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Sarepta Therapeutics Inc is the sale of 3,135 shares on March 5, 2024, which brought Stephen Mayo around $385,480.

According to the SEC Form 4 filings, Stephen Mayo has made a total of 1 transactions in Allogene Therapeutics Inc (ALLO) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Allogene Therapeutics Inc is the sale of 10,000 shares on August 7, 2023, which brought Stephen Mayo around $42,900.

Insider Trading History of Stephen Mayo

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Stephen Mayo Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Stephen Mayo Ownership Network

Ownership Network List of Stephen Mayo

No Data

Ownership Network Relation of Stephen Mayo


Stephen Mayo Owned Company Details

What does Merck & Co Inc do?

Who are the key executives at Merck & Co Inc?

Stephen Mayo is the director of Merck & Co Inc. Other key executives at Merck & Co Inc include EVP & CFO Caroline Litchfield , Evp & Global Svcs & CFO Robert M Davis , and President & Human Health Int?l Joseph Romanelli .

Merck & Co Inc (MRK) Insider Trades Summary

Over the past 18 months, Stephen Mayo made no insider transaction in Merck & Co Inc (MRK). Other recent insider transactions involving Merck & Co Inc (MRK) include a net sale of 108,401 shares made by Steven Mizell , a net sale of 5,715 shares made by Joseph Romanelli , and a net sale of 2,172,853 shares made by Kenneth C Frazier .

In summary, during the past 3 months, insiders sold 309,424 shares of Merck & Co Inc (MRK) in total and bought 0 shares, with a net sale of 309,424 shares. During the past 18 months, 3,477,613 shares of Merck & Co Inc (MRK) were sold and 409 shares were bought by its insiders, resulting in a net sale of 3,477,204 shares.

Merck & Co Inc (MRK)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Merck & Co Inc Insider Transactions

No Available Data

Stephen Mayo Mailing Address

Above is the net worth, insider trading, and ownership report for Stephen Mayo. You might contact Stephen Mayo via mailing address: 2000 Galloping Hill Rd, Kenilworth Nj 07033.

Discussions on Stephen Mayo

No discussions yet.